Related references
Note: Only part of the references are listed.Lipid Management in a Japanese Community: Attainment Rate of Target Set by the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012
Hayato Tada et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2017)
Exome-wide association study of plasma lipids in >300,000 individuals
Dajiang J. Liu et al.
NATURE GENETICS (2017)
Hypertriglyceridaemia and risk of coronary artery disease
Zeljko Reiner
NATURE REVIEWS CARDIOLOGY (2017)
Daily Total Physical Activity and Incident Stroke The Japan Public Health Center-Based Prospective Study
Yasuhiko Kubota et al.
STROKE (2017)
Association of Diabetic Macular Edema and Proliferative Diabetic Retinopathy With Cardiovascular Disease A Systematic Review and Meta-analysis
Jing Xie et al.
JAMA OPHTHALMOLOGY (2017)
Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes
Marshall B. Elam et al.
JAMA CARDIOLOGY (2017)
Management of residual risk after statin therapy
Christina Reith et al.
ATHEROSCLEROSIS (2016)
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2016)
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Alberico L. Catapano et al.
EUROPEAN HEART JOURNAL (2016)
Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia
Roberto Ferrari et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2016)
Rationale and Design of the Standard Versus Intensive Statin Therapy for Hypercholesterolemic Patients with Diabetic Retinopathy (EMPATHY) Study: a Randomized Controlled Trial
Kenji Ueshima et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2016)
Fasting Triglycerides Predict Recurrent Ischemic Events in Patients With Acute Coronary Syndrome Treated With Statins
Gregory G. Schwartz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes Mellitus A Global Case-Control Study in 13 Countries
Frank M. Sacks et al.
CIRCULATION (2014)
Diagnosis of Atherosclerosis Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan-2012 Version
Tamio Teramoto et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2014)
Common variants associated with plasma triglycerides and risk for coronary artery disease
Ron Do et al.
NATURE GENETICS (2013)
Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: A clinical update
Z. Reiner
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2013)
Serum Lipid Levels and the Risk of Intracerebral Hemorrhage: The Rotterdam Study
Renske G. Wieberdink et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Diabetic Retinopathy Predicts All-Cause Mortality and Cardiovascular Events in Both Type 1 and 2 Diabetes Meta-analysis of observational studies
Caroline K. Kramer et al.
DIABETES CARE (2011)
Triglycerides and risk of hemorrhagic stroke vs. ischemic vascular events: The Three-City Study
Audrey Bonaventure et al.
ATHEROSCLEROSIS (2010)
Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients With Coronary Artery Disease
Ole Faergeman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial
Michael Miller et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
Borge G. Nordestgaard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis
Mitsuhiro Yokoyama et al.
LANCET (2007)
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
HM Colhoun et al.
LANCET (2004)
Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions - The Atherosclerosis Risk in Communities (ARIC) Study
AR Sharrett et al.
CIRCULATION (2001)
Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men
MA Austin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2000)